Back
Columbus McKinnon Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
35
CMCO
Columbus McKinnon
Last Price:
$17.70
Seasonality Move:
5.11%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$99.80
Seasonality Move:
6.73%
Sell
35
Columbus McKinnon (CMCO)
is a Sell
Is Columbus McKinnon a Buy, Sell or Hold?
-
The current Columbus McKinnon [CMCO] share price is $17.68. The Score for CMCO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
CMCO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CMCO Stock Price Chart
What is Columbus McKinnon's stock price today?
-
The Columbus McKinnon share price today is $17.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMCO is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $100.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CMCO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.82 | Sell |
Relative Strength Index (14 RSI): | 27.53 | Sell |
Chaikin Money Flow: | 198917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.22 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | 544784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CMCO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.03 | Buy |
20-day SMA: | 19.35 | Sell |
50-day SMA: | 29.5 | Sell |
200-day SMA: | 34.08 | Sell |
8-day EMA: | 17.61 | Buy |
20-day EMA: | 20.56 | Sell |
50-day EMA: | 26.68 | Sell |
200-day EMA: | 33.34 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.91 | Sell |
20-day SMA: | 106.68 | Sell |
50-day SMA: | 114.29 | Sell |
200-day SMA: | 126.68 | Sell |
8-day EMA: | 104.06 | Sell |
20-day EMA: | 106.89 | Sell |
50-day EMA: | 112.29 | Sell |
200-day EMA: | 121 | Sell |
Columbus McKinnon Earnings Growth & CMCO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.49 per share, and an increase next year of $0.30 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Columbus McKinnon Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |